ARCHIVES

In Brief: New Contract To Speed Drug Development Planned; Groups To Get $5.6 Million Extra

This article is from The Cancer Letter archive.

Vol. 02 No. 09 | February 27, 1976

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials

February 24, 2006

Drug Approvals: FDA Grants Accelerated Approval to Imbruvica

November 15, 2013

NCI Programs: Report Calls for Expansion of Colorectal Cancer Research

April 28, 2000

Letter to The Editor: IOM Panel Urges Greater Integration Of Research

February 12, 1999

FDA News:: ODAC Commends Ciba For Design Of Trials Legal Issues:

January 10, 1997

Interim Results Show Vaccine Lowers Breast Cancer Recurrence

December 30, 2011